UTHR
United Therapeutics Corp
$548.80
3.09 (0.57%) Today
6.97 (1.29%) After-hours
— up— down
Market Cap
$23.03B+88.6%
Revenue (TTM)
$2.85B+5.9%
Net Income (TTM)
$1.15B+8.0%
EPS (TTM)
27.09+8.0%
Shares Out
42.45M
42.45MP/E Ratio
17.87
17.87Forward P/E
18.33
18.33Open
$547.42
$547.42Previous Close
$544.92
$544.92Day Range
$535.63 – $552.46
$535.63 – $552.4652-Week Range
$272.12 – $609.35
$272.12 – $609.35Beta
0.59
0.59Volume
529.06K
529.06KAvg Volume
557.35K
557.35KAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout UTHR
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire.
